T Cell Dysfunction in Cancer

Agnellini, 2007, Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection, Proc. Natl. Acad. Sci. USA, 104, 4565, 10.1073/pnas.0610335104 Ahmadzadeh, 2009, Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired, Blood, 114, 1537, 10.1182/blood-2008-12-195792 Ahn, 2016, Demethylation of the PD-1 promoter is imprinted during the effector phase of CD8 T cell exhaustion, J. Virol., 90, 8934, 10.1128/JVI.00798-16 Alexandrov, 2013, Signatures of mutational processes in human cancer, Nature, 500, 415, 10.1038/nature12477 Altman, 2016, From Krebs to clinic: glutamine metabolism to cancer therapy, Nat. Rev. Cancer, 16, 749, 10.1038/nrc.2016.114 Anderson, 2016, Lag-3, Tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation, Immunity, 44, 989, 10.1016/j.immuni.2016.05.001 Ansel, 2000, A chemokine-driven positive feedback loop organizes lymphoid follicles, Nature, 406, 309, 10.1038/35018581 Baitsch, 2011, Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients, J. Clin. Invest., 121, 2350, 10.1172/JCI46102 Baitsch, 2012, Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization, PLoS One, 7, e30852, 10.1371/journal.pone.0030852 Balar, 2017, Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial, Lancet, 389, 67, 10.1016/S0140-6736(16)32455-2 Bandura, 2009, Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry, Anal. Chem., 81, 6813, 10.1021/ac901049w Banerjee, 2010, Cutting edge: the transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche, J. Immunol., 185, 4988, 10.4049/jimmunol.1002042 Benci, 2016, Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade, Cell, 167, 1540, 10.1016/j.cell.2016.11.022 Bengsch, 2016, Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion, Immunity, 45, 358, 10.1016/j.immuni.2016.07.008 Bengsch, 2014, Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation, J. Hepatol., 61, 1212, 10.1016/j.jhep.2014.07.005 Blackburn, 2008, Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade, Proc. Natl. Acad. Sci. USA, 105, 15016, 10.1073/pnas.0801497105 Blackburn, 2009, Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection, Nat. Immunol., 10, 29, 10.1038/ni.1679 Blank, 2016, CANCER IMMUNOLOGY. The “cancer immunogram”, Science, 352, 658, 10.1126/science.aaf2834 Boon, 2006, Human T cell responses against melanoma, Annu. Rev. Immunol., 24, 175, 10.1146/annurev.immunol.24.021605.090733 Borghaei, 2015, Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer, N. Engl. J. Med., 373, 1627, 10.1056/NEJMoa1507643 Bottino, 2003, Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule, J. Exp. Med., 198, 557, 10.1084/jem.20030788 Bour-Jordan, 2011, Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family, Immunol. Rev., 241, 180, 10.1111/j.1600-065X.2011.01011.x Brahmer, 2015, Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer, N. Engl. J. Med., 373, 123, 10.1056/NEJMoa1504627 Carr, 2010, Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation, J. Immunol., 185, 1037, 10.4049/jimmunol.0903586 Carstens, 2017, Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer, Nat. Commun., 8, 15095, 10.1038/ncomms15095 Castle, 2012, Exploiting the mutanome for tumor vaccination, Cancer Res., 72, 1081, 10.1158/0008-5472.CAN-11-3722 Chang, 2013, Posttranscriptional control of T cell effector function by aerobic glycolysis, Cell, 153, 1239, 10.1016/j.cell.2013.05.016 Chang, 2015, Metabolic competition in the tumor microenvironment is a driver of cancer progression, Cell, 162, 1229, 10.1016/j.cell.2015.08.016 Chauvin, 2015, TIGIT and PD-1 impair tumor antigen-specific CD8(+) T cells in melanoma patients, J. Clin. Invest., 125, 2046, 10.1172/JCI80445 Chemnitz, 2004, SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation, J. Immunol., 173, 945, 10.4049/jimmunol.173.2.945 Chen, 2013, Oncology meets immunology: the cancer-immunity cycle, Immunity, 39, 1, 10.1016/j.immuni.2013.07.012 Chen, 2016, Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade, Cancer Discov., 6, 827, 10.1158/2159-8290.CD-15-1545 Chen, 2015, Combination of 4-1BB agonist and PD-1 antagonist promotes antitumor effector/memory CD8 T cells in a poorly immunogenic tumor model, Cancer Immunol. Res., 3, 149, 10.1158/2326-6066.CIR-14-0118 Chevrier, 2017, An immune atlas of clear cell renal cell carcinoma, Cell, 169, 736, 10.1016/j.cell.2017.04.016 Choi, 2013, Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?, J. Pathol., 230, 350, 10.1002/path.4218 Chung, 2017, Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer, Nat. Commun., 8, 15081, 10.1038/ncomms15081 Croft, 2010, Control of immunity by the TNFR-related molecule OX40 (CD134), Annu. Rev. Immunol., 28, 57, 10.1146/annurev-immunol-030409-101243 Crotty, 2011, Follicular helper CD4 T cells (TFH), Annu. Rev. Immunol., 29, 621, 10.1146/annurev-immunol-031210-101400 Day, 2006, PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, 443, 350, 10.1038/nature05115 Di Caro, 2014, Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers, Clin. Cancer Res., 20, 2147, 10.1158/1078-0432.CCR-13-2590 Dieu-Nosjean, 2008, Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures, J. Clin. Oncol., 26, 4410, 10.1200/JCO.2007.15.0284 Doedens, 2013, Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen, Nat. Immunol., 14, 1173, 10.1038/ni.2714 Doering, 2012, Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory, Immunity, 37, 1130, 10.1016/j.immuni.2012.08.021 Duraiswamy, 2013, Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors, Cancer Res., 73, 3591, 10.1158/0008-5472.CAN-12-4100 Efremova, 2018, Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution, Nat. Commun., 9, 32, 10.1038/s41467-017-02424-0 Erkes, 2017, Virus-specific CD8+ T cells infiltrate melanoma lesions and retain function independently of pd-1 expression, J. Immunol., 198, 2979, 10.4049/jimmunol.1601064 Fehlings, 2017, Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8(+) T cells, Nat. Commun., 8, 562, 10.1038/s41467-017-00627-z Fehrenbacher, 2016, Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial, Lancet, 387, 1837, 10.1016/S0140-6736(16)00587-0 Fernandez-Poma, 2017, Expansion of tumor-infiltrating CD8+ T cells expressing PD-1 improves the efficacy of adoptive T-cell therapy, Cancer Res., 77, 3672, 10.1158/0008-5472.CAN-17-0236 Fischer, 2007, Inhibitory effect of tumor cell-derived lactic acid on human T cells, Blood, 109, 3812, 10.1182/blood-2006-07-035972 Fourcade, 2010, Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients, J. Exp. Med., 207, 2175, 10.1084/jem.20100637 Frauwirth, 2002, The CD28 signaling pathway regulates glucose metabolism, Immunity, 16, 769, 10.1016/S1074-7613(02)00323-0 Fridman, 2012, The immune contexture in human tumours: impact on clinical outcome, Nat. Rev. Cancer, 12, 298, 10.1038/nrc3245 Fridman, 2017, The immune contexture in cancer prognosis and treatment, Nat. Rev. Clin. Oncol., 14, 717, 10.1038/nrclinonc.2017.101 Fuertes Marraco, 2015, Inhibitory receptors beyond T cell exhaustion, Front. Immunol., 6, 310, 10.3389/fimmu.2015.00310 Gabrilovich, 1998, Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo, Blood, 92, 4150, 10.1182/blood.V92.11.4150 Gajewski, 2013, Innate and adaptive immune cells in the tumor microenvironment, Nat. Immunol., 14, 1014, 10.1038/ni.2703 Ghoneim, 2017, De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation, Cell, 170, 142, 10.1016/j.cell.2017.06.007 Giesen, 2014, Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry, Nat. Methods, 11, 417, 10.1038/nmeth.2869 Giordano, 2015, Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion, EMBO J., 34, 2042, 10.15252/embj.201490786 Goc, 2014, Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells, Cancer Res., 74, 705, 10.1158/0008-5472.CAN-13-1342 Gropper, 2017, Culturing CTLs under hypoxic conditions enhances their cytolysis and improves their anti-tumor function, Cell Rep., 20, 2547, 10.1016/j.celrep.2017.08.071 Gros, 2016, Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients, Nat. Med., 22, 433, 10.1038/nm.4051 Gros, 2014, PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors, J. Clin. Invest., 124, 2246, 10.1172/JCI73639 Grosso, 2009, Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells, J. Immunol., 182, 6659, 10.4049/jimmunol.0804211 Hall, 2013, Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene, Oncotarget, 4, 584, 10.18632/oncotarget.965 Haq, 2013, Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF, Cancer Cell, 23, 302, 10.1016/j.ccr.2013.02.003 He, 2016, Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection, Nature, 537, 412, 10.1038/nature19317 Heindl, 2015, Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology, Lab. Invest., 95, 377, 10.1038/labinvest.2014.155 Ho, 2015, Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses, Cell, 162, 1217, 10.1016/j.cell.2015.08.012 Hodi, 2010, Improved survival with ipilimumab in patients with metastatic melanoma, N. Engl. J. Med., 363, 711, 10.1056/NEJMoa1003466 Hugo, 2015, Non-genomic and immune evolution of melanoma acquiring MAPKi resistance, Cell, 162, 1271, 10.1016/j.cell.2015.07.061 Hui, 2017, T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition, Science, 355, 1428, 10.1126/science.aaf1292 Im, 2016, Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy, Nature, 537, 417, 10.1038/nature19330 Intlekofer, 2005, Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin, Nat. Immunol., 6, 1236, 10.1038/ni1268 Jin, 2010, Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection, Proc. Natl. Acad. Sci. USA, 107, 14733, 10.1073/pnas.1009731107 Johnston, 2014, The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function, Cancer Cell, 26, 923, 10.1016/j.ccell.2014.10.018 Julliard, 2014, The aryl hydrocarbon receptor meets immunology: friend or foe? A little of both, Front. Immunol., 5, 458, 10.3389/fimmu.2014.00458 Kamphorst, 2017, Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent, Science, 355, 1423, 10.1126/science.aaf0683 Kao, 2011, Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection, Nat. Immunol., 12, 663, 10.1038/ni.2046 Kato, 2013, Acidic extracellular microenvironment and cancer, Cancer Cell Int., 13, 89, 10.1186/1475-2867-13-89 Khalili, 2012, Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma, Clin. Cancer Res., 18, 5329, 10.1158/1078-0432.CCR-12-1632 Kim, 2010, Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance, Nature, 467, 328, 10.1038/nature09370 Kjaergaard, 2000, Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth, Cancer Res., 60, 5514 Koyama, 2016, Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints, Nat. Commun., 7, 10501, 10.1038/ncomms10501 Kroeger, 2016, Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer, Clin. Cancer Res., 22, 3005, 10.1158/1078-0432.CCR-15-2762 Kroenke, 2012, Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation, J. Immunol., 188, 3734, 10.4049/jimmunol.1103246 Krummel, 1995, CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation, J. Exp. Med., 182, 459, 10.1084/jem.182.2.459 Kuchroo, 2014, Coinhibitory receptors and CD8 T cell exhaustion in chronic infections, Curr. Opin. HIV AIDS, 9, 439, 10.1097/COH.0000000000000088 Kurtulus, 2015, TIGIT predominantly regulates the immune response via regulatory T cells, J. Clin. Invest., 125, 4053, 10.1172/JCI81187 Kvistborg, 2014, Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response, Sci. Transl. Med., 6, 254ra128, 10.1126/scitranslmed.3008918 Kvistborg, 2012, TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients, Oncoimmunology, 1, 409, 10.4161/onci.18851 Larkin, 2015, Combined nivolumab and ipilimumab or monotherapy in untreated melanoma, N. Engl. J. Med., 373, 23, 10.1056/NEJMoa1504030 Lavin, 2017, Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses, Cell, 169, 750, 10.1016/j.cell.2017.04.014 Legat, 2013, Inhibitory receptor expression depends more dominantly on differentiation and activation than “exhaustion” of human CD8 T cells, Front. Immunol., 4, 455, 10.3389/fimmu.2013.00455 Li, 2016, Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: evidence for intracellular cross talk, Oncoimmunology, 5, e1200778, 10.1080/2162402X.2016.1200778 Lind, 2004, Arginine and cancer, J. Nutr., 134, 2837S, 10.1093/jn/134.10.2837S Lu, 2017, Tumor antigen-specific CD8+ T cells are negatively regulated by PD-1 and Tim-3 in human gastric cancer, Cell. Immunol., 313, 43, 10.1016/j.cellimm.2017.01.001 Ma, 2013, Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy, Cancer Discov., 3, 418, 10.1158/2159-8290.CD-12-0383 MacIver, 2013, Metabolic regulation of T lymphocytes, Annu. Rev. Immunol., 31, 259, 10.1146/annurev-immunol-032712-095956 Martinez-Outschoorn, 2017, Cancer metabolism: a therapeutic perspective, Nat. Rev. Clin. Oncol., 14, 11, 10.1038/nrclinonc.2016.60 Matsushita, 2012, Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting, Nature, 482, 400, 10.1038/nature10755 Matsuzaki, 2010, Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer, Proc. Natl. Acad. Sci. USA, 107, 7875, 10.1073/pnas.1003345107 McGranahan, 2016, Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade, Science, 351, 1463, 10.1126/science.aaf1490 Medaglia, 2017, Spatial reconstruction of immune niches by combining photoactivatable reporters and scRNA-seq, Science, 358, 1622, 10.1126/science.aao4277 Mellman, 2011, Cancer immunotherapy comes of age, Nature, 480, 480, 10.1038/nature10673 Mognol, 2017, Exhaustion-associated regulatory regions in CD8(+) tumor-infiltrating T cells, Proc. Natl. Acad. Sci. USA, 114, E2776, 10.1073/pnas.1620498114 Motzer, 2015, Nivolumab versus everolimus in advanced renal-cell carcinoma, N. Engl. J. Med., 373, 1803, 10.1056/NEJMoa1510665 Munder, 2009, L-arginine deprivation impairs Leishmania major-specific T-cell responses, Eur. J. Immunol., 39, 2161, 10.1002/eji.200839041 Muul, 1987, Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma, J. Immunol., 138, 989, 10.4049/jimmunol.138.3.989 Nagarsheth, 2017, Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy, Nat. Rev. Immunol., 17, 559, 10.1038/nri.2017.49 Odorizzi, 2015, Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells, J. Exp. Med., 212, 1125, 10.1084/jem.20142237 Ornatsky, 2010, Highly multiparametric analysis by mass cytometry, J. Immunol. Methods, 361, 1, 10.1016/j.jim.2010.07.002 Paley, 2012, Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection, Science, 338, 1220, 10.1126/science.1229620 Park, 2016, TGFbeta1-mediated SMAD3 enhances PD-1 expression on antigen-specific T cells in cancer, Cancer Discov., 6, 1366, 10.1158/2159-8290.CD-15-1347 Parry, 2005, CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms, Mol. Cell. Biol., 25, 9543, 10.1128/MCB.25.21.9543-9553.2005 Pasetto, 2016, Tumor- and neoantigen-reactive T-cell receptors can be identified based on their frequency in fresh tumor, Cancer Immunol. Res., 4, 734, 10.1158/2326-6066.CIR-16-0001 Patel, 2017, Identification of essential genes for cancer immunotherapy, Nature, 548, 537, 10.1038/nature23477 Pauken, 2016, Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade, Science, 354, 1160, 10.1126/science.aaf2807 Pearce, 2013, Metabolic pathways in immune cell activation and quiescence, Immunity, 38, 633, 10.1016/j.immuni.2013.04.005 Peng, 2015, Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy, Nature, 527, 249, 10.1038/nature15520 Peng, 2016, Loss of PTEN promotes resistance to T cell-mediated immunotherapy, Cancer Discov., 6, 202, 10.1158/2159-8290.CD-15-0283 Philip, 2017, Chromatin states define tumour-specific T cell dysfunction and reprogramming, Nature, 545, 452, 10.1038/nature22367 Pilon-Thomas, 2016, Neutralization of tumor acidity improves antitumor responses to immunotherapy, Cancer Res., 76, 1381, 10.1158/0008-5472.CAN-15-1743 Platten, 2012, Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion, Cancer Res., 72, 5435, 10.1158/0008-5472.CAN-12-0569 Pollok, 1993, Inducible T cell antigen 4-1BB. Analysis of expression and function, J. Immunol., 150, 771, 10.4049/jimmunol.150.3.771 Poschke, 2016, Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma, Oncoimmunology, 5, e1240859, 10.1080/2162402X.2016.1240859 Quigley, 2010, Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF, Nat. Med., 16, 1147, 10.1038/nm.2232 Restifo, 1996, Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy, J. Natl. Cancer Inst., 88, 100, 10.1093/jnci/88.2.100 Robbins, 2013, Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells, Nat. Med., 19, 747, 10.1038/nm.3161 Robert, 2015, Nivolumab in previously untreated melanoma without BRAF mutation, N. Engl. J. Med., 372, 320, 10.1056/NEJMoa1412082 Robert, 2014, Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial, Lancet, 384, 1109, 10.1016/S0140-6736(14)60958-2 Robert, 2011, Ipilimumab plus dacarbazine for previously untreated metastatic melanoma, N. Engl. J. Med., 364, 2517, 10.1056/NEJMoa1104621 Rosenberg, 2016, Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial, Lancet, 387, 1909, 10.1016/S0140-6736(16)00561-4 Sakuishi, 2010, Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity, J. Exp. Med., 207, 2187, 10.1084/jem.20100643 Sautes-Fridman, 2016, Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention, Front. Immunol., 7, 407, 10.3389/fimmu.2016.00407 Scharping, 2016, Tumor microenvironment metabolism: a new checkpoint for anti-tumor immunity, Vaccines (Basel), 4, E46, 10.3390/vaccines4040046 Scharping, 2016, The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction, Immunity, 45, 701, 10.1016/j.immuni.2016.08.009 Schietinger, 2016, Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis, Immunity, 45, 389, 10.1016/j.immuni.2016.07.011 Schreiber, 2011, Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion, Science, 331, 1565, 10.1126/science.1203486 Schreiner, 2016, Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptor, Oncoimmunology, 5, e1062969, 10.1080/2162402X.2015.1062969 Scott-Browne, 2016, Dynamic changes in chromatin accessibility occur in CD8(+) T cells responding to viral infection, Immunity, 45, 1327, 10.1016/j.immuni.2016.10.028 Seiwert, 2016, Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial, Lancet Oncol., 17, 956, 10.1016/S1470-2045(16)30066-3 Sen, 2016, The epigenetic landscape of T cell exhaustion, Science, 354, 1165, 10.1126/science.aae0491 Shayan, 2017, Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer, Oncoimmunology, 6, e1261779, 10.1080/2162402X.2016.1261779 Shin, 2009, A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection, Immunity, 31, 309, 10.1016/j.immuni.2009.06.019 Shrimali, 2017, Concurrent PD-1 blockade negates the effects of OX40 agonist antibody in combination immunotherapy through inducing T-cell apoptosis, Cancer Immunol. Res., 5, 755, 10.1158/2326-6066.CIR-17-0292 Simon, 2016, PD-1 expression conditions T cell avidity within an antigen-specific repertoire, Oncoimmunology, 5, e1104448, 10.1080/2162402X.2015.1104448 Simpson, 2013, Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma, J. Exp. Med., 210, 1695, 10.1084/jem.20130579 Singer, 2016, A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells, Cell, 166, 1500, 10.1016/j.cell.2016.08.052 Siska, 2017, Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma, JCI Insight, 2, 10.1172/jci.insight.93411 Speiser, 2016, Regulatory circuits of T cell function in cancer, Nat. Rev. Immunol., 16, 599, 10.1038/nri.2016.80 Spranger, 2015, Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity, Nature, 523, 231, 10.1038/nature14404 Staron, 2014, The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection, Immunity, 41, 802, 10.1016/j.immuni.2014.10.013 Stephens, 2009, Complex landscapes of somatic rearrangement in human breast cancer genomes, Nature, 462, 1005, 10.1038/nature08645 Sun, 2015, IL-10 and PD-1 cooperate to limit the activity of tumor-specific CD8+ T cells, Cancer Res., 75, 1635, 10.1158/0008-5472.CAN-14-3016 te Raa, 2014, CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia, Blood, 123, 717, 10.1182/blood-2013-08-518183 Teft, 2009, Structure-Function analysis of the CTLA-4 interaction with PP2A, BMC Immunol., 10, 23, 10.1186/1471-2172-10-23 Terme, 2013, VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer, Cancer Res., 73, 539, 10.1158/0008-5472.CAN-12-2325 Thommen, 2015, Progression of lung cancer is associated with increased dysfunction of T cells defined by coexpression of multiple inhibitory receptors, Cancer Immunol. Res., 3, 1344, 10.1158/2326-6066.CIR-15-0097 Tirosh, 2016, Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq, Science, 352, 189, 10.1126/science.aad0501 Topalian, 1989, Tumor-specific cytolysis by lymphocytes infiltrating human melanomas, J. Immunol., 142, 3714, 10.4049/jimmunol.142.10.3714 Tran, 2008, Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy, J. Immunother., 31, 742, 10.1097/CJI.0b013e31818403d5 Trautmann, 2006, Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction, Nat. Med., 12, 1198, 10.1038/nm1482 Tumeh, 2014, PD-1 blockade induces responses by inhibiting adaptive immune resistance, Nature, 515, 568, 10.1038/nature13954 Utzschneider, 2016, T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections, Immunity, 45, 415, 10.1016/j.immuni.2016.07.021 van der Windt, 2013, CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability, Proc. Natl. Acad. Sci. USA, 110, 14336, 10.1073/pnas.1221740110 van der Windt, 2012, Metabolic switching and fuel choice during T-cell differentiation and memory development, Immunol. Rev., 249, 27, 10.1111/j.1600-065X.2012.01150.x van Rooij, 2013, Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma, J. Clin. Oncol., 31, e439, 10.1200/JCO.2012.47.7521 Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809 Walunas, 2011, Pillars article: CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1994. 1: 405–413, J. Immunol., 187, 3466 Wang, 2011, The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation, Immunity, 35, 871, 10.1016/j.immuni.2011.09.021 Watts, 2010, Staying alive: T cell costimulation, CD28, and Bcl-xL, J. Immunol., 185, 3785, 10.4049/jimmunol.1090085 Wei, 2014, Dual targeting of CD137 co-stimulatory and PD-1 co-inhibitory molecules for ovarian cancer immunotherapy, Oncoimmunology, 3, e28248, 10.4161/onci.28248 Wei, 2013, Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatin, PLoS One, 8, e84927, 10.1371/journal.pone.0084927 Weinberg, 2000, Engagement of the OX-40 receptor in vivo enhances antitumor immunity, J. Immunol., 164, 2160, 10.4049/jimmunol.164.4.2160 Wherry, 2011, T cell exhaustion, Nat. Immunol., 12, 492, 10.1038/ni.2035 Wherry, 2007, Molecular signature of CD8+ T cell exhaustion during chronic viral infection, Immunity, 27, 670, 10.1016/j.immuni.2007.09.006 Wilson, 2011, Targeting hypoxia in cancer therapy, Nat. Rev. Cancer, 11, 393, 10.1038/nrc3064 Wlodarchak, 2016, PP2A as a master regulator of the cell cycle, Crit. Rev. Biochem. Mol. Biol., 51, 162, 10.3109/10409238.2016.1143913 Wolchok, 2013, Nivolumab plus ipilimumab in advanced melanoma, N. Engl. J. Med., 369, 122, 10.1056/NEJMoa1302369 Wu, 2001, The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors, Oncogene, 20, 6018, 10.1038/sj.onc.1204699 Xia, 2017, Suppression of FIP200 and autophagy by tumor-derived lactate promotes naive T cell apoptosis and affects tumor immunity, Sci. Immunol., 2, 10.1126/sciimmunol.aan4631 Youngblood, 2013, Cutting edge: prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells, J. Immunol., 191, 540, 10.4049/jimmunol.1203161 Youngblood, 2011, Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells, Immunity, 35, 400, 10.1016/j.immuni.2011.06.015 Yu, 2009, The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells, Nat. Immunol., 10, 48, 10.1038/ni.1674 Yuan, 2012, Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling, Sci. Transl. Med., 4, 157ra143, 10.1126/scitranslmed.3004330 Zajac, 1998, Viral immune evasion due to persistence of activated T cells without effector function, J. Exp. Med., 188, 2205, 10.1084/jem.188.12.2205 Zaretsky, 2016, Mutations associated with acquired resistance to PD-1 blockade in melanoma, N. Engl. J. Med., 375, 819, 10.1056/NEJMoa1604958 Zarour, 2016, Reversing T-cell dysfunction and exhaustion in cancer, Clin. Cancer Res., 22, 1856, 10.1158/1078-0432.CCR-15-1849 Zhang, 2014, Epigenetic manipulation restores functions of defective CD8(+) T cells from chronic viral infection, Mol. Ther., 22, 1698, 10.1038/mt.2014.91 Zhang, 2016, Starved and asphyxiated: how can CD8(+) T cells within a tumor microenvironment prevent tumor progression, Front. Immunol., 7, 32, 10.3389/fimmu.2016.00032 Zheng, 2017, Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing, Cell, 169, 1342, 10.1016/j.cell.2017.05.035 Zheng, 2009, Anergic T cells are metabolically anergic, J. Immunol., 183, 6095, 10.4049/jimmunol.0803510 Zhou, 2010, Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1, Immunity, 33, 229, 10.1016/j.immuni.2010.08.002 Zhu, 2015, A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4+ T cell receptor repertoire clonality, Oncoimmunology, 4, e1051922, 10.1080/2162402X.2015.1051922 Zippelius, 2004, Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance, Cancer Res., 64, 2865, 10.1158/0008-5472.CAN-03-3066